0 Σχόλια
0 Μοιράστηκε
234 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Biosimilar Bevacizumab Market – Affordable Oncology Care Increasing Treatment AccessMarket Overview Cancer care can place significant financial pressure on patients, hospitals, insurers, and national healthcare systems. Biologic medicines have transformed treatment in many oncology settings, but their high cost can restrict access or strain budgets. Biosimilars are designed to be highly similar to approved reference biologic medicines, with no clinically meaningful differences...0 Σχόλια 0 Μοιράστηκε 223 Views 0 Προεπισκόπηση
-
Oncology Biosimilar Market to Reach USD 36.90 Billion by 2034, Growing at a CAGR of 18.5%The global Oncology Biosimilar Market is experiencing substantial growth, driven by the increasing prevalence of cancer worldwide, rising demand for cost-effective biologic therapies, and favorable regulatory frameworks supporting biosimilar approvals. Oncology biosimilars are emerging as a viable alternative to expensive biologic drugs, improving patient access to advanced cancer...0 Σχόλια 0 Μοιράστηκε 481 Views 0 Προεπισκόπηση